{"schema_version":"secwatch.filing_event.v1","accession":"0000081362-25-000012","form_type":"8-K","ticker":"KWR","cik":"0000081362","company_name":"QUAKER CHEMICAL CORP","filed_at":"2025-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.410625+00:00","generated_at":"2026-05-26T06:37:21.274287+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Quaker Houghton Q4 net sales down 5% to $444M; adj. EPS drops to $1.33","bullets":["Q4 net sales $444.1M, down 5% YoY; net income $14.2M ($0.81 diluted EPS) vs $20.2M ($1.12) prior year.","Non-GAAP EPS $1.33 vs $1.78; adjusted EBITDA $64.8M vs $77.0M, down 16%.","Full year net sales $1.84B, net income $116.6M ($6.51 EPS); operating cash flow $204.6M.","Americas segment sales down 8%; EMEA down 7%; Asia/Pacific up 5% on new business wins.","Company expects at least $20M cost savings in 2025 and revenue, EBITDA, earnings growth."],"urls":{"canonical":"https://secwatch.observer/filing/0000081362-25-000012","json":"https://secwatch.observer/filing/0000081362-25-000012.json","markdown":"https://secwatch.observer/filing/0000081362-25-000012.md","text":"https://secwatch.observer/filing/0000081362-25-000012.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/81362/000008136225000012/0000081362-25-000012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/81362/000008136225000012/kwr-20250224.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T06:37:21.274287+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}